Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-01-13 Sale |
2023-01-18 5:30 pm |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
5,000 | $50.53 | $252,651 | 81,268 (Direct) |
View |
| 2023-01-03 Sale |
2023-01-05 6:46 pm |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
25,000 | $51.27 | $1,281,751 | 556,867 (Direct) |
View |
| 2023-01-03 Sale |
2023-01-05 5:56 pm |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
8,777 | $54.64 | $479,560 | 328,232 (Indirect Direct) |
View |
| 2022-12-28 Sale |
2022-12-30 4:26 pm |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
22,016 | $50.97 | $1,122,125 | 330,882 (Direct) |
View |
| 2022-12-27 Sale |
2022-12-29 5:41 pm |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
20,000 | $49.77 | $995,323 | 508,281 (Direct) |
View |
| 2022-12-27 Sale |
2022-12-28 6:30 pm |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
12,500 | $49.57 | $619,609 | 383,025 (Indirect Direct) |
View |
| 2022-12-12 Sale |
2022-12-13 8:24 pm |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
5,000 | $43.23 | $216,137 | 172,647 (Direct) |
View |
| 2022-12-01 Sale |
2022-12-05 4:36 pm |
Akero Therapeutics Inc. | AKRO | Skorpios Trust Blue Horizon Enterprise Ltd Ezbon International Ltd Montrago Trustees Ltd Former 10% owner |
1,636,000 | $43.5 | $71,166,000 | 3,271,829 (Indirect) |
View |
| 2022-12-01 Sale |
2022-12-02 5:52 pm |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
10,000 | $46.07 | $460,700 | 521,016 (Direct) |
View |
| 2022-11-30 Sale |
2022-12-02 5:48 pm |
Akero Therapeutics Inc. | AKRO | Harrison Seth Loring Director |
23,131 | $46.94 | $1,085,739 | 284,364 (Indirect Direct) |
View |
| 2022-11-15 Sale |
2022-11-16 7:15 pm |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
7,085 | $45.28 | $320,806 | 183,837 (Direct) |
View |
| 2022-11-10 Sale |
2022-11-14 5:26 pm |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
5,000 | $39.42 | $197,105 | 72,073 (Direct) |
View |
| 2022-11-01 Sale |
2022-11-02 9:52 pm |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
10,000 | $43.42 | $434,183 | 531,016 (Direct) |
View |
| 2022-10-28 Sale |
2022-11-01 5:38 pm |
Akero Therapeutics Inc. | AKRO | Harrison Seth Loring Director |
44,103 | $40.31 | $1,777,829 | 307,495 (Indirect Direct) |
View |
| 2022-10-25 Sale |
2022-10-27 9:50 pm |
Akero Therapeutics Inc. | AKRO | Harrison Seth Loring Director |
285,487 | $42.71 | $12,193,196 | 351,598 (Indirect Direct) |
View |
| 2022-10-25 Sale |
2022-10-27 9:27 pm |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
15,415 | $45.07 | $694,782 | 314,930 (Direct) |
View |
| 2022-10-25 Sale |
2022-10-27 9:25 pm |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
12,500 | $44.72 | $558,944 | 283,510 (Indirect Direct) |
View |
| 2022-09-13 Sale(A) |
2022-10-27 9:23 pm |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
22,500 | $29.18 | $656,550 | 296,593 (Direct) |
View |
| 2022-10-13 Sale |
2022-10-17 5:40 pm |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
20,000 | $39.82 | $796,400 | 266,258 (Direct) |
View |
| 2022-10-10 Sale |
2022-10-12 4:59 pm |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
5,000 | $37.99 | $189,950 | 77,073 (Direct) |
View |
| 2022-10-06 Sale |
2022-10-07 6:00 pm |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
22,500 | $39.29 | $884,025 | 247,665 (Direct) |
View |
| 2022-10-03 Sale |
2022-10-05 08:55 am |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
10,000 | $33.23 | $332,279 | 541,016 (Direct) |
View |
| 2022-09-30 Sale |
2022-10-04 8:57 pm |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
45,000 | $32.72 | $1,472,400 | 336,593 (Direct) |
View |
| 2022-09-13 Sale |
2022-09-15 7:59 pm |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
60,000 | $27.42 | $1,645,444 | 551,016 (Direct) |
View |
| 2022-09-13 Sale |
2022-09-15 7:59 pm |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
40,000 | $27.48 | $1,099,228 | 82,073 (Direct) |
View |
| 2022-09-13 Sale |
2022-09-15 7:57 pm |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
32,500 | $27.03 | $878,341 | 286,258 (Direct) |
View |
| 2022-09-13 Sale |
2022-09-15 7:56 pm |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
22,500 | $29.18 | $656,550 | 223,837 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-01-10 Option Award |
2023-01-11 7:51 pm |
N/A 2033-01-09 |
Akero Therapeutics Inc. | AKRO | Lamy Patrick See Remarks |
100,000 | $0 | 100,000 (Direct) |
View |
| 2023-01-03 Exercise |
2023-01-05 6:46 pm |
N/A 2028-10-17 |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
25,000 | $0 | 556,867 (Direct) |
View |
| 2023-01-03 Exercise |
2023-01-05 6:46 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
25,000 | $0.615 | 556,867 (Direct) |
View |
| 2023-01-03 Exercise |
2023-01-05 5:56 pm |
N/A 2028-10-17 |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
8,777 | $0 | 328,232 (Direct) |
View |
| 2023-01-03 Exercise |
2023-01-05 5:56 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
8,777 | $0.615 | 328,232 (Direct) |
View |
| 2022-12-28 Exercise |
2022-12-30 4:26 pm |
N/A 2030-12-07 |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
9,516 | $0 | 330,882 (Direct) |
View |
| 2022-12-28 Exercise |
2022-12-30 4:26 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
9,516 | $28.35 | 330,882 (Direct) |
View |
| 2022-12-27 Exercise |
2022-12-29 5:41 pm |
N/A 2029-04-04 |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
20,000 | $0 | 508,281 (Direct) |
View |
| 2022-12-27 Exercise |
2022-12-29 5:41 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
20,000 | $7.009 | 508,281 (Direct) |
View |
| 2022-12-27 Exercise |
2022-12-28 6:30 pm |
N/A 2029-01-15 |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
12,500 | $0 | 383,025 (Direct) |
View |
| 2022-12-27 Exercise |
2022-12-28 6:30 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
11,778 | $6.36 | 383,025 (Direct) |
View |
| 2022-12-27 Exercise |
2022-12-28 6:30 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
722 | $0.615 | 383,025 (Direct) |
View |
| 2022-12-16 Option Award |
2022-12-20 7:52 pm |
N/A 2031-12-07 |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
29,073 | $0 | 87,221 (Direct) |
View |
| 2022-12-16 Option Award |
2022-12-20 7:49 pm |
N/A 2031-12-07 |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
29,073 | $0 | 87,221 (Direct) |
View |
| 2022-12-16 Option Award |
2022-12-20 7:49 pm |
N/A 2031-12-07 |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
29,073 | $0 | 87,221 (Direct) |
View |
| 2022-12-16 Option Award |
2022-12-20 7:47 pm |
N/A 2031-12-07 |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
29,073 | $0 | 87,221 (Direct) |
View |
| 2022-12-16 Exercise |
2022-12-20 7:46 pm |
N/A 2028-09-07 |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
8,500 | $0 | 829,873 (Direct) |
View |
| 2022-12-16 Option Award |
2022-12-20 7:46 pm |
N/A 2031-12-07 |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
87,220 | $0 | 829,873 (Direct) |
View |
| 2022-12-16 Exercise |
2022-12-20 7:46 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
8,500 | $0.615 | 829,873 (Direct) |
View |
| 2022-12-09 Option Award |
2022-12-13 8:30 pm |
N/A 2032-12-08 |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
287,931 | $0 | 598,079 (Direct) |
View |
| 2022-12-09 Option Award |
2022-12-13 8:30 pm |
N/A 2032-12-08 |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
105,574 | $0 | 289,411 (Direct) |
View |
| 2022-12-09 Option Award |
2022-12-13 8:30 pm |
N/A 2032-12-08 |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
105,574 | $0 | 328,828 (Direct) |
View |
| 2022-12-09 Option Award |
2022-12-13 8:28 pm |
N/A 2032-12-08 |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
105,574 | $0 | 110,003 (Direct) |
View |
| 2022-12-09 Option Award |
2022-12-13 8:24 pm |
N/A 2032-12-08 |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
105,574 | $0 | 172,647 (Direct) |
View |
| 2022-12-01 Exercise |
2022-12-02 5:52 pm |
N/A 2028-10-17 |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
10,000 | $0 | 521,016 (Direct) |
View |
| 2022-12-01 Exercise |
2022-12-02 5:52 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
10,000 | $0.615 | 521,016 (Direct) |
View |
| 2022-11-01 Exercise |
2022-11-02 9:52 pm |
N/A 2028-10-17 |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
10,000 | $0 | 531,016 (Direct) |
View |
| 2022-11-01 Exercise |
2022-11-02 9:52 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
10,000 | $0.615 | 531,016 (Direct) |
View |
| 2022-10-25 Exercise |
2022-10-27 9:27 pm |
N/A 2029-01-15 |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
10,000 | $0 | 314,930 (Direct) |
View |
| 2022-10-25 Exercise |
2022-10-27 9:27 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
8,203 | $6.36 | 314,930 (Direct) |
View |
| 2022-10-25 Exercise |
2022-10-27 9:27 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
1,797 | $28.35 | 314,930 (Direct) |
View |
| 2022-10-25 Exercise |
2022-10-27 9:25 pm |
N/A 2029-01-15 |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
12,500 | $0 | 283,510 (Direct) |
View |
| 2022-10-25 Exercise |
2022-10-27 9:25 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
12,500 | $6.36 | 283,510 (Direct) |
View |
| 2022-09-13 Exercise(A) |
2022-10-27 9:23 pm |
N/A 2029-01-15 |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
10,000 | $0 | 296,593 (Direct) |
View |
| 2022-09-13 Exercise(A) |
2022-10-27 9:23 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
10,000 | $6.36 | 296,593 (Direct) |
View |
| 2022-10-13 Exercise |
2022-10-17 5:40 pm |
N/A 2029-04-04 |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
20,000 | $0 | 266,258 (Direct) |
View |
| 2022-10-13 Exercise |
2022-10-17 5:40 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
20,000 | $7.009 | 266,258 (Direct) |
View |
| 2022-10-06 Exercise |
2022-10-07 6:00 pm |
N/A 2029-12-12 |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
10,000 | $0 | 247,665 (Direct) |
View |
| 2022-10-06 Exercise |
2022-10-07 6:00 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
10,000 | $21.09 | 247,665 (Direct) |
View |
| 2022-10-03 Exercise |
2022-10-05 08:55 am |
N/A 2028-10-17 |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
10,000 | $0 | 541,016 (Direct) |
View |
| 2022-10-03 Exercise |
2022-10-05 08:55 am |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
10,000 | $0.615 | 541,016 (Direct) |
View |
| 2022-09-30 Exercise |
2022-10-04 8:57 pm |
N/A 2029-01-15 |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
20,000 | $0 | 336,593 (Direct) |
View |
| 2022-09-30 Exercise |
2022-10-04 8:57 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
6,328 | $6.36 | 336,593 (Direct) |
View |
| 2022-09-30 Exercise |
2022-10-04 8:57 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
13,672 | $21.09 | 336,593 (Direct) |
View |
| 2022-09-13 Exercise |
2022-09-15 7:59 pm |
N/A 2028-10-17 |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
60,000 | $0 | 551,016 (Direct) |
View |
| 2022-09-13 Exercise |
2022-09-15 7:59 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
60,000 | $0.615 | 551,016 (Direct) |
View |
| 2022-09-13 Exercise |
2022-09-15 7:57 pm |
N/A 2029-04-04 |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
32,500 | $0 | 286,258 (Direct) |
View |
| 2022-09-13 Exercise |
2022-09-15 7:57 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
32,500 | $7.009 | 286,258 (Direct) |
View |
| 2022-09-09 Option Award |
2022-09-13 9:16 pm |
N/A 2031-12-07 |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
58,148 | $0 | 87,222 (Direct) |
View |
| 2022-09-09 Option Award |
2022-09-13 9:15 pm |
N/A 2031-12-07 |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
58,148 | $0 | 209,295 (Direct) |
View |
| 2022-06-30 Option Award |
2022-09-13 9:15 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
1,152 | $8.03 | 209,295 (Direct) |
View |